Literature DB >> 29671168

Multiple sclerosis in the Republic of San Marino, Italian peninsula: an incidence and prevalence study from a high-risk area.

Marta Caniglia-Tenaglia1, Susanna Guttmann2, Chiara Monaldini2, Dario Manzaroli2, Mirco Volpini2, Maurizio Stumpo2, Elisabetta Groppo1, Ilaria Casetta1, Vittorio Govoni1, Mattia Fonderico1, Maura Pugliatti1, Enrico Granieri3.   

Abstract

Epidemiological studies on multiple sclerosis (MS) carried out in Southern Europe in the last years have shown a significant increase in the disease frequency. Previous surveys conducted in the Republic of San Marino, Northern Italian peninsula, identified that the population is at high risk for MS, with a prevalence of 51.6 per 100,000 population in 1982 and of 166.7 in 2005 and with a mean annual incidence of 7.9 per 100,000 for the period 1990-2005. The present work is a community-based intensive prevalence and incidence survey, by a complete enumeration approach, to update the prevalence and incidence of MS in the Republic of San Marino. The mean annual incidence for the period 2005-14 was 7.7 (95% CI 4.9-11.4) per 100,000, 3.3 (95% CI 1.1-7.6) for men and 11.9 (95% CI 7.2-18.6) for women. On 31 December 2014, 67 patients (19 men and 48 women), suffering from definite or probable MS and living in the Republic of San Marino, yielded a crude prevalence of 204.3 (95% CI 158.4-259.5) per 100,000, 117.8 (95% CI 70.9-183.7) for men and 288.2 (95% CI 212.4-383.3) for women. Our study has confirmed San Marino is an area at high risk for MS, in line with epidemiological data from continental Italy. The marked increase in MS prevalence over time in this population can be ascribable to increased survival and improved ascertainment, in the presence of a substantially stable, yet high, incidence rate.

Entities:  

Keywords:  Epidemiology; Incidence; Multiple sclerosis; Prevalence; Republic of San Marino

Mesh:

Year:  2018        PMID: 29671168     DOI: 10.1007/s10072-018-3402-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  32 in total

1.  High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta, Sicily, southern Italy.

Authors:  Luigi M E Grimaldi; Barbara Palmeri; Giuseppe Salemi; Giuseppe Giglia; Marco D'Amelio; Roberto Grimaldi; Gaetano Vitello; Paolo Ragonese; Giovanni Savettieri
Journal:  Neuroepidemiology       Date:  2006-12-08       Impact factor: 3.282

2.  Incidence of multiple sclerosis in the general population in the Netherlands, 1996-2008.

Authors:  M A Kramer; N A T van der Maas; E M van Soest; J M Kemmeren; H E de Melker; M C J M Sturkenboom
Journal:  Neuroepidemiology       Date:  2012-07-17       Impact factor: 3.282

3.  Epidemiology of multiple sclerosis in Italy and in southern Europe.

Authors:  E Granieri; I Casetta; M R Tola
Journal:  Acta Neurol Scand Suppl       Date:  1995

Review 4.  Mortality study on multiple sclerosis in the province of Ferrara, northern Italy, 1968 through 1989.

Authors:  V Govoni; I Casetta; E Granieri; V Vernonesi; S Malagù; M R Tola; E Paolino; E Fainardi; V C Monetti; I Aiello
Journal:  Acta Neurol (Napoli)       Date:  1993-06

5.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

6.  The epidemiology of multiple sclerosis in Scotland: inferences from hospital admissions.

Authors:  Adam E Handel; Lynne Jarvis; Ryan McLaughlin; Anastasia Fries; George C Ebers; Sreeram V Ramagopalan
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

7.  Multiple sclerosis in Iceland, with observations on the alleged epidemic in the Faroe Islands.

Authors:  J Benedikz; H Magnússon; G Guthmundsson
Journal:  Ann Neurol       Date:  1994-12       Impact factor: 10.422

Review 8.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

9.  A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.

Authors:  N Grytten; J H Aarseth; H M B Lunde; K M Myhr
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-02-24       Impact factor: 10.154

10.  Geographical variations in sex ratio trends over time in multiple sclerosis.

Authors:  Maria Trojano; Guglielmo Lucchese; Giusi Graziano; Bruce V Taylor; Steve Simpson; Vito Lepore; Francois Grand'maison; Pierre Duquette; Guillermo Izquierdo; Pierre Grammond; Maria Pia Amato; Roberto Bergamaschi; Giorgio Giuliani; Cavit Boz; Raymond Hupperts; Vincent Van Pesch; Jeannette Lechner-Scott; Edgardo Cristiano; Marcela Fiol; Celia Oreja-Guevara; Maria Laura Saladino; Freek Verheul; Mark Slee; Damiano Paolicelli; Carla Tortorella; Mariangela D'Onghia; Pietro Iaffaldano; Vita Direnzo; Helmut Butzkueven
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

View more
  3 in total

1.  The use of Modified Rio score for determining treatment failure in patients with multiple sclerosis: retrospective descriptive case series study.

Authors:  Mesude Tutuncu; Ayse Altintas; Burcu V Dogan; Ugur Uygunoglu; Nilufer Kale Icen; Ayse Deniz Elmalı; Eda Coban; Bengi G Alpaslan; Aysun Soysal
Journal:  Acta Neurol Belg       Date:  2020-08-31       Impact factor: 2.396

2.  Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil.

Authors:  Vijayalakshmi Vasanthaprasad; Vivek Khurana; Sreelatha Vadapalle; Jackie Palace; Nicholas Adlard
Journal:  BMC Neurol       Date:  2022-08-17       Impact factor: 2.903

Review 3.  Multiple sclerosis epidemiological trends in Italy highlight the environmental risk factors.

Authors:  M Puthenparampil; P Perini; R Bergamaschi; M Capobianco; M Filippi; P Gallo
Journal:  J Neurol       Date:  2021-09-27       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.